# Intravenous Remifentanil for Labor Analgesia

> **NCT00710086** · PHASE4 · COMPLETED · sponsor: **Nanjing Medical University** · enrollment: 1000 (actual)

## Conditions studied

- Labor Pain

## Interventions

- **DRUG:** Hydromorphone
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT00710086
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2009-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710086, "Intravenous Remifentanil for Labor Analgesia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00710086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*